Sequencing the Single Cancer Cell | Adventures in Genomics

August 11, 2015

 

Single cell sequencing is revolutionizing our understanding of the mechanism of tumor progression, tumor development, and metastasis. This may ultimately lead to improved cancer detection, diagnosis, and treatment. Subscribe to Illumina: http://bit.ly/IlluminaYouTube


Links: 
www.illumina.com/science/education/adventures-in-genomics.ilmn


Nick Navin at The University of Texas MD Anderson Cancer Center --http://faculty.mdanderson.org/Nicholas_Navin/Default.asp?SNID=2113230403


For more info on applications in cancer - www.illumina.com/applications/cancer/research.ilmn


For more info on applications in other areas
www.illumina.com/science/publications/publications-review.ilmn

 


The Adventures in Genomics video series hosted by the Illumina Scientific Affairs team. Embark on a fascinating journey, exploring amazing discoveries and meeting the scientists behind the breakthroughs who are helping us better understand ourselves and the world around us.

See all our Adventures in Genomics videos:
https://www.youtube.com/playlist?list=PLKRu7cmBQlah8wHBByBXEO0dNW-xNvvX_

Share this article on    
    
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see www.illumina.com/company/legal.html.

© 2024 Illumina, Inc. All rights reserved.